作者
Rodrigo Nalio Ramos,Yoann Missolo-Koussou,Yohan Gerber-Ferder,Christian P. Bromley,Mattia Bugatti,Nicolás Gonzalo Núñez,Jimena Tosello,Wilfrid Richer,Laurie Menger,Jordan Denizeau,Christine Sedlik,Pamela Caudana,Fiorella Kotsias,Leticia Laura Niborski,Sophie Viel,Mylène Bohec,Sonia Lameiras,Sylvain Baulande,Laëtitia Lesage,Nicolás André,Didier Meseure,Anne Vincent‐Salomon,Fabien Reyal,Charles‐Antoine Dutertre,Florent Ginhoux,Lene Vimeux,Emmanuel Donnadieu,Bénédicte Buttard,Jérôme Galon,Santiago Zelenay,William Vermi,Pierre Guermonprez,Eliane Piaggio,Julie Helft
摘要
Macrophage infiltration is a hallmark of solid cancers, and overall macrophage infiltration correlates with lower patient survival and resistance to therapy. Tumor-associated macrophages, however, are phenotypically and functionally heterogeneous. Specific subsets of tumor-associated macrophage might be endowed with distinct roles on cancer progression and antitumor immunity. Here, we identify a discrete population of FOLR2+ tissue-resident macrophages in healthy mammary gland and breast cancer primary tumors. FOLR2+ macrophages localize in perivascular areas in the tumor stroma, where they interact with CD8+ T cells. FOLR2+ macrophages efficiently prime effector CD8+ T cells ex vivo. The density of FOLR2+ macrophages in tumors positively correlates with better patient survival. This study highlights specific roles for tumor-associated macrophage subsets and paves the way for subset-targeted therapeutic interventions in macrophages-based cancer therapies.